• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于在体内和体外研究ras致癌作用的基因定义的正常人类体细胞系统。

A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro.

作者信息

O'Hayer Kevin M, Counter Christopher M

机构信息

Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA.

出版信息

Methods Enzymol. 2006;407:637-47. doi: 10.1016/S0076-6879(05)07050-3.

DOI:10.1016/S0076-6879(05)07050-3
PMID:16757358
Abstract

Transgenic mice, cultured murine cells, and human cancer cell lines have widely been used to study Ras oncogenesis. Although extremely valuable systems, they could not be used to study Ras function in genetically defined human cells. In this regard, Ras is required for tumor formation in normal human somatic cells expressing SV-40 T/t antigens, which inactivate the tumor suppressors p53 and Rb and activate the oncogene c-Myc, and hTERT, the catalytic subunit of telomerase. Such a system allows not only the general requirements of Ras to be dissected in matched cells from different organisms or tissues but also the individual pathways required for tumor growth to be defined in human cells. This review will detail the methods of creating stable T/t Ag, TERT, Ras-expressing cell lines, as well as commonly used techniques of soft agar and xenograft tumor formation.

摘要

转基因小鼠、培养的鼠细胞和人类癌细胞系已被广泛用于研究Ras致癌作用。尽管它们是极有价值的系统,但无法用于研究Ras在基因定义的人类细胞中的功能。在这方面,在表达SV-40 T/t抗原的正常人类体细胞中,Ras是肿瘤形成所必需的,SV-40 T/t抗原会使肿瘤抑制因子p53和Rb失活,并激活癌基因c-Myc以及端粒酶的催化亚基hTERT。这样的系统不仅能在来自不同生物体或组织的匹配细胞中剖析Ras的一般需求,还能在人类细胞中确定肿瘤生长所需的各个途径。本综述将详细介绍创建稳定表达T/t抗原、TERT和Ras的细胞系的方法,以及常用的软琼脂和异种移植肿瘤形成技术。

相似文献

1
A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro.一种用于在体内和体外研究ras致癌作用的基因定义的正常人类体细胞系统。
Methods Enzymol. 2006;407:637-47. doi: 10.1016/S0076-6879(05)07050-3.
2
Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma.经基因改造的人类星形胶质细胞形成颅内肿瘤,确定了人类间变性星形细胞瘤发展过程中至关重要的四条途径。
Cancer Res. 2001 Jul 1;61(13):4956-60.
3
A genetically tractable model of human glioma formation.一种用于人类胶质瘤形成的遗传易处理模型。
Cancer Res. 2001 May 1;61(9):3556-60.
4
Use of Ras-transformed human ovarian surface epithelial cells as a model for studying ovarian cancer.使用Ras转化的人卵巢表面上皮细胞作为研究卵巢癌的模型。
Methods Enzymol. 2006;407:660-76. doi: 10.1016/S0076-6879(05)07052-7.
5
Cell lines with heterogeneous phenotypes result from a single isolation of albumin-sv40 T-antigen transgenic rat hepatocytes.具有异质表型的细胞系源自白蛋白 - sv40 T抗原转基因大鼠肝细胞的单次分离。
Hepatology. 1997 May;25(5):1192-203. doi: 10.1002/hep.510250523.
6
c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1.Ras转化需要c-Jun氨基末端激酶2,且不依赖于激活蛋白1。
Cancer Res. 2007 Jan 1;67(1):178-85. doi: 10.1158/0008-5472.CAN-06-2801.
7
Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.利用特定细胞癌基因对人卵巢表面上皮细胞进行致癌转化。
Carcinogenesis. 2009 Mar;30(3):423-31. doi: 10.1093/carcin/bgp007. Epub 2009 Jan 6.
8
[The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].c-myc/K-ras诱导的小鼠卵巢表面上皮细胞(MOSE)转化
Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):881-5.
9
K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.K-Ras通过Raf和磷脂酰肌醇3激酶信号通路促进永生化人胰腺细胞的生长转化和侵袭。
Cancer Res. 2007 Mar 1;67(5):2098-106. doi: 10.1158/0008-5472.CAN-06-3752.
10
Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.反义人端粒酶逆转录酶可在体外部分逆转胃癌细胞系的恶性表型。
Eur J Cancer Prev. 2008 Jun;17(3):209-17. doi: 10.1097/CEJ.0b013e3282b71f0d.

引用本文的文献

1
Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis.体内基因操控内源性 Kras 水平和致癌突变影响小鼠肿瘤发生的组织模式。
Elife. 2022 Sep 7;11:e75715. doi: 10.7554/eLife.75715.
2
Autophagy Is Polarized toward Cell Front during Migration and Spatially Perturbed by Oncogenic Ras.自噬在迁移过程中向细胞前缘极化,并被致癌性 Ras 空间干扰。
Cells. 2021 Oct 2;10(10):2637. doi: 10.3390/cells10102637.
3
Capturing the primordial Kras mutation initiating urethane carcinogenesis.
捕获引发尿烷致癌的原始 Kras 突变。
Nat Commun. 2020 Apr 14;11(1):1800. doi: 10.1038/s41467-020-15660-8.
4
Localization of RalB signaling at endomembrane compartments and its modulation by autophagy.RalB 信号在细胞内膜区室中的定位及其被自噬调控。
Sci Rep. 2019 Jun 20;9(1):8910. doi: 10.1038/s41598-019-45443-1.
5
RalB directly triggers invasion downstream Ras by mobilizing the Wave complex.RalB 通过动员 Wave 复合物直接触发下游 Ras 的入侵。
Elife. 2018 Oct 15;7:e40474. doi: 10.7554/eLife.40474.
6
Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability.探究 RAS 异构体的蛋白质互作组,鉴定出 PIP5K1A 是 KRAS 特异性的弱点。
Nat Commun. 2018 Sep 7;9(1):3646. doi: 10.1038/s41467-018-05692-6.
7
Copper Chelation as Targeted Therapy in a Mouse Model of Oncogenic BRAF-Driven Papillary Thyroid Cancer.铜螯合作用作为一种靶向治疗在致癌 BRAF 驱动的甲状腺乳头状癌小鼠模型中的应用。
Clin Cancer Res. 2018 Sep 1;24(17):4271-4281. doi: 10.1158/1078-0432.CCR-17-3705. Epub 2018 Jul 31.
8
Copper Chelation Inhibits BRAF-Driven Melanomagenesis and Counters Resistance to BRAF and MEK1/2 Inhibitors.铜螯合作用可抑制BRAF驱动的黑色素瘤发生,并对抗对BRAF和MEK1/2抑制剂的耐药性。
Cancer Res. 2017 Nov 15;77(22):6240-6252. doi: 10.1158/0008-5472.CAN-16-1190. Epub 2017 Oct 6.
9
Analysis of post-transcriptional regulation during cancer progression using a donor-derived isogenic model of tumorigenesis.利用供体衍生的肿瘤发生同基因模型分析癌症进展过程中的转录后调控。
Methods. 2017 Aug 15;126:193-200. doi: 10.1016/j.ymeth.2017.05.012. Epub 2017 May 19.
10
Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma.组成性 IRAK4 激活是胰腺导管腺癌预后不良和化疗耐药的基础。
Clin Cancer Res. 2017 Apr 1;23(7):1748-1759. doi: 10.1158/1078-0432.CCR-16-1121. Epub 2016 Oct 4.